Literature DB >> 10993684

EGF infusion stimulates the proliferation and migration of embryonic progenitor cells transplanted in the adult rat striatum.

R A Fricker-Gates1, C Winkler, D Kirik, C Rosenblad, M K Carpenter, A Björklund.   

Abstract

Immature progenitor cells (generated by in vitro propagation) may provide a useful alternative to primary cells (from dissected embryonic tissue) for transplantation if their migratory and proliferative and differentiation properties can be controlled and directed in vivo. In this study E15 murine EGF-responsive progenitor cells were transplanted to the striatum of adult rats. Simultaneously, these animals received continuous infusion of either epidermal growth factor (EGF) or vehicle, to the lateral ventricle, for 8 days. In animals that received EGF, the transplanted progenitors migrated toward the lateral ventricle and proliferated, as evidenced by bromodeoxyuridine incorporation. Progenitor cells transplanted to rats that received vehicle infusions showed neither of these responses. In all animals, transplanted progenitors expressed an immature astrocyte or oligodendrocyte phenotype, the majority of cells being astrocytes. We conclude that EGF stimulates the migration and proliferation of murine progenitor cells in vivo, either directly or indirectly, but does not influence their phenotypic differentiation. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10993684     DOI: 10.1006/exnr.2000.7482

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  11 in total

Review 1.  Cell therapy in demyelinating diseases.

Authors:  Claire Rice; Christopher Halfpenny; Neil Scolding
Journal:  NeuroRx       Date:  2004-10

Review 2.  Cell therapy for multiple sclerosis.

Authors:  Tamir Ben-Hur
Journal:  Neurotherapeutics       Date:  2011-10       Impact factor: 7.620

3.  GABAergic neurons from mouse embryonic stem cells possess functional properties of striatal neurons in vitro, and develop into striatal neurons in vivo in a mouse model of Huntington's disease.

Authors:  Eunju Shin; Mary J Palmer; Meng Li; Rosemary A Fricker
Journal:  Stem Cell Rev Rep       Date:  2012-06       Impact factor: 5.739

4.  N-syndecan deficiency impairs neural migration in brain.

Authors:  Anni Hienola; Sarka Tumova; Evgeny Kulesskiy; Heikki Rauvala
Journal:  J Cell Biol       Date:  2006-08-14       Impact factor: 10.539

5.  Human pluripotent stem cell therapy for Huntington's disease: technical, immunological, and safety challenges human pluripotent stem cell therapy for Huntington's disease: technical, immunological, and safety challenges.

Authors:  Camille Nicoleau; Pedro Viegas; Marc Peschanski; Anselme L Perrier
Journal:  Neurotherapeutics       Date:  2011-10       Impact factor: 7.620

6.  Allelic variation in the Tyk2 and EGF genes as potential genetic determinants of CNS repair.

Authors:  Allan J Bieber; Kanitta Suwansrinon; Jason Kerkvliet; Weidong Zhang; Larry R Pease; Moses Rodriguez
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

7.  EGF amplifies the replacement of parvalbumin-expressing striatal interneurons after ischemia.

Authors:  Tetsuyuki Teramoto; Jianhua Qiu; Jean-Christophe Plumier; Michael A Moskowitz
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

Review 8.  Predictive and prognostic markers in human glioblastomas.

Authors:  Kamalakannan Palanichamy; Michael Erkkinen; Arnab Chakravarti
Journal:  Curr Treat Options Oncol       Date:  2006-11

9.  Analysis of FK506-mediated functional recovery and neuroprotection in a rat model of spinal cord injury indicates that EGF is modulated in astrocytes.

Authors:  Jun Cai; Yu Sun; Zaoyang Yin; Daode Wang; Kun Shi; Yuxuan Fu; Xiaojian Cao; Yingbin Ge
Journal:  Exp Ther Med       Date:  2018-06-08       Impact factor: 2.447

10.  Regulation of brain tumor dispersal by NKCC1 through a novel role in focal adhesion regulation.

Authors:  Tomas Garzon-Muvdi; Paula Schiapparelli; Colette ap Rhys; Hugo Guerrero-Cazares; Christopher Smith; Deok-Ho Kim; Lyonell Kone; Harrison Farber; Danielle Y Lee; Steven S An; Andre Levchenko; Alfredo Quiñones-Hinojosa
Journal:  PLoS Biol       Date:  2012-05-01       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.